Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
| Actual shortage: | 240 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-GEMFIBROZIL | 600MG | TABLET | Actual shortage | 2024-05-30 | 2024-05-30 | 229233 |
| TEVA-CLOBAZAM | 10MG | TABLET | Actual shortage | 2024-05-30 | 2024-05-30 | 229230 |
| TEVA-ENTACAPONE | 200MG | TABLET | Actual shortage | 2024-05-30 | 2024-05-30 | 229227 |
| TEVA-LACOSAMIDE | 50MG | TABLET | Resolved | 2024-03-18 | 2024-05-30 | 222575 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2021-12-17 | 2024-05-30 | 151465 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2023-06-19 | 2024-05-30 | 195481 |
| TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2024-03-28 | 2024-05-30 | 223850 |
| TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2024-02-01 | 2024-05-30 | 218137 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2024-03-07 | 2024-05-30 | 221540 |
| TEVA-NITROFURANTOIN | 100MG | CAPSULE | Resolved | 2024-02-15 | 2024-05-30 | 219677 |
| TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2024-05-09 | 2024-05-30 | 227489 |
| TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2024-03-18 | 2024-05-30 | 222569 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2023-06-19 | 2024-05-30 | 195456 |
| TEVA-FENTANYL | 25MCG | PATCH | Resolved | 2024-02-01 | 2024-05-30 | 218132 |
| TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-02-09 | 2024-05-30 | 184216 |
| TEVA-ROPINIROLE | 5MG | TABLET | Resolved | 2021-04-01 | 2024-05-30 | 136751 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Actual shortage | 2024-05-16 | 2024-05-30 | 228149 |
| TEVA-SALBUTAMOL STERINEBS P.F. | 2MG | SOLUTION | Actual shortage | 2024-02-22 | 2024-05-30 | 220261 |
| ACT METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-05-16 | 2024-05-30 | 228143 |
| TEVA-SUCRALFATE | 1G | TABLET | Actual shortage | 2023-12-14 | 2024-05-30 | 213368 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
| TEVA-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14007 |